Quest Diagnostics

6 days ago · zacks.com

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

6 days ago · seekingalpha.com

Quest Diagnostics is upgraded to a strong buy, driven by robust earnings momentum, sector resilience, and sustained outperformance versus benchmarks. DGX delivered its fourth consecutive earnings beat, with Q3 revenue up 10% YoY and EPS up 28.7%, prompting raised full-year guidance. Quest's competitive edge is reinforced by superior margins, a strong ROE above 15%, ongoing innovation, and an investment-grade balance sheet with declining leverage.

10 days ago · businesswire.com

SAN FRANCISCO--(BUSINESS WIRE)--AWKO Law LLP is investigating a data breach that led to unauthorized access to the sensitive information of patients of Quest Diagnostics, a New Jersey-based diagnostic testing company. Quest Diagnostics disclosed in its Securities and Exchange Commission (“SEC”) Form 8-K filing that on October 21, 2026, it identified unauthorized activity in its Quanum Lab Services Manager, a platform where certain clients can place test orders and receive or look up their resul.

10 days ago · techcrunch.com

Medical lab testing giant Quest Diagnostics has confirmed a cyberattack and data breach affecting an as-yet unspecified amount of sensitive patient information stored in its systems, according to a legally required disclosure with U.S. regulators.

10 days ago · zacks.com

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

11 days ago · zacks.com

Quest Diagnostics beats Q3 earnings and revenue estimates, raises its 2026 outlook on strong testing demand and margin gains, yet shares dip in pre-market trading.

11 days ago · marketbeat.com

Quest Diagnostics NYSE: DGX reported third-quarter 2026 revenue growth of 10% and adjusted earnings-per-share growth of more than 15%, citing demand across its physician, hospital and consumer channels as well as productivity gains from automation and artificial intelligence. The company raised and narrowed its full-year revenue and earnings outlook.

11 days ago · fool.com

Quest Diagnostics expects consumer health revenue growth to exceed 30% in 2026. Organic requisition volume increased 14.4% in the third quarter of 2026.

11 days ago · seekingalpha.com

Quest Diagnostics Incorporated (DGX) Q3 2026 Earnings Call Transcript

11 days ago · benzinga.com

Quest Diagnostics Incorporated (NYSE:DGX) on Thursday reported third-quarter adjusted earnings of $3 per share, beating the Wall Street estimate of $2.86.